Screening, assessment, and management of fatigue in adult survivors of cancer: An American Society of Clinical Oncology clinical practice guideline adaptation Review uri icon

Overview

MeSH Major

  • Fatigue
  • Neoplasms
  • Survivors

abstract

  • Fatigue is prevalent in cancer survivors and often causes significant disruption in functioning and quality of life. Regular screening, assessment, and education and appropriate treatment of fatigue are important in managing this distressing symptom. Given the multiple factors contributing to post-treatment fatigue, interventions should be tailored to each patient's specific needs. In particular, a number of nonpharmacologic treatment approaches have demonstrated efficacy in cancer survivors.

publication date

  • June 10, 2014

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC4039870

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.53.4495

PubMed ID

  • 24733803

Additional Document Info

start page

  • 1840

end page

  • 50

volume

  • 32

number

  • 17